BRUCE D. BROUSSARD - 24 Feb 2023 Form 4 Insider Report for HUMANA INC (HUM)

Role
President & CEO, Director
Signature
Bruce D. Broussard
Issuer symbol
HUM
Transactions as of
24 Feb 2023
Net transactions value
-$14,461,571
Form type
4
Filing time
28 Feb 2023, 13:19:21 UTC
Previous filing
19 Dec 2022
Next filing
26 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUM Humana Common Options Exercise $0 +28,494 +41% $0.000000 98,534 24 Feb 2023 Direct F9
transaction HUM Humana Common Tax liability $5,571,338 -10,919 -11% $510.24 87,615 24 Feb 2023 Direct F10
transaction HUM Humana Common Sale $8,890,233 -17,575 -20% $505.85 70,040 27 Feb 2023 Direct F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Options Award $0 +26,484 $0.000000 26,484 24 Feb 2023 Humana Common 26,484 $510.24 Direct F4
transaction HUM Restricted Stock Units Award $0 +6,859 $0.000000 6,859 24 Feb 2023 Humana Common 6,859 Direct F5, F8
holding HUM Options 13,430 24 Feb 2023 Humana Common 13,430 $350.79 Direct F1
holding HUM Options 30,425 24 Feb 2023 Humana Common 30,425 $376.61 Direct F2
holding HUM Options 23,734 24 Feb 2023 Humana Common 23,734 $425.06 Direct F3
holding HUM Restricted Stock Units 2,465 24 Feb 2023 Humana Common 2,465 Direct F5, F6
holding HUM Restricted Stock Units 4,368 24 Feb 2023 Humana Common 4,368 Direct F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments.
F2 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24.
F3 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25.
F4 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F5 Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F6 Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
F7 Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F8 Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F9 Performance Stock Units vested on 2/24/23, not required to be reported until vest.
F10 Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23.
F11 Price reported is weighted average sales price.